Hepatitis E ; immunology ; prevention & control ; Humans ; Viral Hepatitis Vaccines

Hepatitis B ; immunology ; prevention & control ; Hepatitis B Vaccines ; immunology

This paper summarizes the incidence, modes of transmission, diagnosis, treatment and prevention of chronic hepatitis E.
Humans ; Hepatitis E/prevention & control* ; Hepatitis, Chronic/epidemiology* ; Incidence

In Vietnam, the rate of chronic hepatitis B was very high (15-20%). The rate of chronic hepatitis C (was 2-3%) but increasingly. Especially, these rates among addicts were very high. They were two major causes of the primary liver cancer, followed by alcoholism and use of aflatoxin. Therefore, the program of primary liver cancer prevention should concentrate the hepatitis B and hepatitis C prevention and control a well as risk of alcoholism and use of aflatoxin
Liver Neoplasms ; Hepatitis B ; prevention & control

The study aims at description of awarness and practicr of B virus hepatitis control in 190 pregnant women in Cau Giay District, Ha Noi City, year 2002. It is a described horiziontal analytical in vestigation. Subjects were interviewed with structural questions. The data were analyzied by Epi-info 6.04 software and test X2 . Results showed a very low level of knowledge and practice skills. Influenced factors are educational level and professional skill as well as information resources. It must be recommended to promote the couselling at commune health station with concise messages. Further studies must be conducted in other districts in the city
Hepatitis B ; Pregnant Women ; Knowledge ; prevention & control

China ; Hepatitis C ; prevention & control ; therapy ; Humans

Hepatitis C ; prevention & control ; therapy ; Humans

This consensus was developed by Chinese Society of Hepatology, Chinese Medical Association. It includes introduction, etiology, epidemiology and prevention, pathology, laboratory examination, clinical manifestation, treatment, issues to be studied and solved.
Consensus ; Gastroenterology ; Hepatitis E/prevention & control* ; Humans

In 2006, 2014 and 2020, the positive rates of HBsAg in 560, 384 and 402 children aged 1 to 14 years were 4.5%, 2.6% and 2.5%, respectively, with no statistically significant differences (P>0.05). The positive rate of anti-HBs was highest in 2014 (57.8%) and lowest in 2006 (34.1%) (P<0.05). The positive rate of anti-HBc was highest in 2006 (15.7%), and decreased in 2014 (7.8%) and 2020 (5.7%) (P<0.001). The timely rate of the first dose of hepatitis B vaccine for children in Lhasa in 2006, 2014 and 2020 was 7.7% (43/560), 50.3% (193/384) and 94.8% (381/402), respectively. The overall vaccination rates were 15.4% (86/560), 35.2% (135/384) and 96.0% (386/402), respectively, showing a trend of gradual increases (χtrend values were 718.63 and 589.59, both P values<0.001).
Child ; Humans ; Hepatitis B Vaccines ; Hepatitis B/prevention & control* ; Hepatitis B Surface Antigens ; Hepatitis B virus ; Hepatitis B Antibodies ; Vaccination

Hepatitis B ; prevention & control ; transmission ; Hepatitis B virus ; Humans ; Infectious Disease Transmission, Vertical ; prevention & control